Methimazole - CAS 60-56-0
Catalog number: 60-56-0
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C4H6N2S
Molecular Weight:
114.17
COA:
Inquire
Targets:
Others
Description:
Methimazole (also known as Tapazole or Thiamazole or MMI) is an antithyroid drug,and part of the thioamide group. Like its counterpart propylthiouracil, a major side effect of treatment is agranulocytosis.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
MSDS:
Inquire
1.SERIAL CHANGES OF LIVER FUNCTION TESTS BEFORE AND DURING METHIMAZOLE TREATMENT IN THYROTOXIC PATIENTS.
Niculescu DA1, Dusceac R2, Galoiu SA1, Capatina CA1, Poiana C1. Endocr Pract. 2016 Apr 4. [Epub ahead of print]
Objective Overt hyperthyroidism and methimazole (MMI) treatment are frequently associated with abnormal liver function tests (LFT). We describe the serial changes of LFT in MMI-treated hyperthyroid patients. Methods We retrospectively analyzed all 77 patients presenting with newly diagnosed overt hyperthyroidism (59 Graves diseases, 11 toxic nodular goiters, 4 toxic adenomas, 3 amiodarone-induced thyrotoxicosis) between 2012-2014. All patients started MMI 10 to 60 mg/day that was gradually tapered. We measeured TSH, freeT4, alanine aminotransferase (ALT) and aspartate aminotrasnferase (AST) at baseline and at 6 weeks, 4.5 months and 10 months after starting the MMI treatment. The concomitant medication was stable during MMI treatment. Results At baseline, 25 patients (32.5%) had abnormal LFT, of which 5 had ALT or AST levels over 2 × upper limit of normal (ULN). In most patients with baseline abnormal LFT, MMI treatment resulted in a normalization of serum ALT and AST.
2.Hampered Lung Maturation in Methimazole-Induced Hypothyroidism in Fetal Chicken: Morphological and Molecular Correlates to Human Fetal Development.
Bjørnstad S1, Samara A, Erichsen A, Paulsen RE, Glover JC, Roald B. Neonatology. 2016;110(2):83-92. doi: 10.1159/000444656. Epub 2016 Apr 13.
BACKGROUND: Molecular understanding of lung development is crucial for developing therapies and diagnostic tools. Animal models with altered thyroid hormone signaling provide mechanistic insight into thyroid-dependent neonatal lung disease. Repression of Klf2 (Krüppel-like factor 2), a suggested T3 target gene, is associated with disrupted lung development in mice. Klf2 is proposed to be specifically involved in type I pneumocyte differentiation.
3.Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report.
Cunha FM1,2, Rodrigues E3,4, Oliveira J3,4, Saavedra A3,4, Vinhas LS5, Carvalho D3,4. J Med Case Rep. 2016 Mar 31;10(1):70. doi: 10.1186/s13256-016-0878-7.
BACKGROUND: Thyrotoxicosis after total thyroidectomy is mostly iatrogenic. Rarely, a hyperfunctional thyroid remnant or ectopic tissue may be the cause. There are few cases of Graves' disease arising from thyroid tissue located in the mediastinum and none in which Graves' disease was diagnosed only after surgery. We report the case of a patient with Graves's disease in a mediastinal thyroid mass presenting 7 years after total thyroidectomy for nontoxic goiter.
4.Predicting relapse of Graves' disease following treatment with antithyroid drugs.
Liu L1, Lu H1, Liu Y2, Liu C1, Xun C3. Exp Ther Med. 2016 Apr;11(4):1453-1458. Epub 2016 Feb 9.
The aim of the present study was to monitor long term antithyroid drug treatments and to identify prognostic factors for Graves' disease (GD). A total of 306 patients with GD who were referred to the Endocrinology Clinic at Weifang People's Hospital (Weifang, China) between August 2005 and June 2009 and treated with methimazole were included in the present study. Following treatment, patients were divided into non-remission, including recurrence and constant treatment subgroups, and remission groups. Various prognosis factors were analyzed and compared, including: Patient age, gender, size of thyroid prior to and following treatment, thyroid hormone levels, disease relapse, hypothyroidism and drug side-effects, and states of thyrotropin suppression were observed at 3, 6 and 12 months post-treatment. Sixty-five patients (21.2%) were male, and 241 patients (78.8%) were female. The mean age was 42±11 years, and the follow-up was 31.5±6.8 months.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 76822-21-4 Danshensu

Danshensu
(CAS: 76822-21-4)

Danshensu is an active component of Salvia miltiorrhiza that shows wide cardiovascular benefit. It suppresses the formation of reactive oxygen species and inhib...

CAS 13171-25-0 Trimetazidine dihydrochloride

Trimetazidine dihydrochloride
(CAS: 13171-25-0)

Trimetazidine dihydrochloride, a piperazine derivative, could reduce fatty acid β-oxidation and used as a coronary vasodilator.

CAS 465-39-4 Resibufogenin

Resibufogenin
(CAS: 465-39-4)

Resibufogenin influenced peak amplitude, overshoot and half-width of the evoked single action potential, and simultaneously lessened the firing rate of evoked r...

V5 Epitope Tag Peptide

V5 Epitope Tag Peptide, a tag peptide derived from a small epitope present on the P and V proteins of the paramyxovirus of simian virus 5, is used as a blocking...

GNE-3500
(CAS: 1537859-24-7)

GNE-3500 has been found to be a Retinoic acid receptor-related Orphan receptor C agonist that could be probably significant in studies of some inflammatory dise...

CAS 145821-59-6 Tiagabine hydrochloride

Tiagabine hydrochloride
(CAS: 145821-59-6)

Tiagabine hydrochloride is an anticonvulsant and selective GABA reuptake inhibitor through inhibition of the synaptic GABA transporter GAT1. Tiagabine increases...

CAS 645-43-2 Guanethidine sulfate

Guanethidine sulfate
(CAS: 645-43-2)

Guanethidine is an antihypertensive drug that reduces the release of catecholamines, such as norepinephrine. It is transported across the sympathetic nerve memb...

NSC659000
(CAS: 139449-81-3)

NSC659000 is a potential antifungal agent. It is one of the 3-(3-methyl-5-isoxazolyl)-2-styrylquinazolin-4(3H)-ones derivatives that be synthesized for antifung...

MK-142 dimethanesulfonate
(CAS: 42794-63-8)

MK-142 is a bioactive agent with antiarrhythmic properties with its content in the skeletal muscles indicates a high affinity of the examined substance to the ...

CAS 106635-80-7 Tafenoquine

Tafenoquine
(CAS: 106635-80-7)

Tafenoquine is an oral active and an 8-aminoquinoline antimalaria drug. It is being investigated as a potential treatment for malaria, as well as for malaria pr...

CAS 478-01-3 Nobiletin

Nobiletin
(CAS: 478-01-3)

Nobiletin, a citrus flavonoid isolated from citrus peels like in tangerine, which has anti-inflammatory and anti-tumor activities.

CAS 32462-30-9 L-p-Hydroxyphenyglycine

L-p-Hydroxyphenyglycine
(CAS: 32462-30-9)

L-p-Hydroxyphenyglycines a carnitine is a palmitoyltransferase-1 inhibitor, improves whole-body glucose tolerance and insulin sensitivity in high-fat diet-induc...

SV40 large T antigen NLS

SV40 large T antigen NLS, a hexamer protein generated from Large T antigen residue 47 to 55, enables protein import into cell nucleus.

LY-280748
(CAS: 153226-99-4)

LY-280748, a tetrazol derivative, could probably be significant in some studies for its biological activities.

FR-218944
(CAS: 233264-02-3)

FR-218944 is a vasopressin antagonist compound.

CAS 880090-88-0 Neuropathiazol

Neuropathiazol
(CAS: 880090-88-0)

Neuropathiazol is a synthetic small molecule that induces neuronal differentiation of adult hippocampal neural progenitor cells. It selectively induces neuronal...

CAS 7432-28-2 Schisandrin

Schisandrin
(CAS: 7432-28-2)

Schisandrin has various therapeutic effects on a range of medical conditions such as anti-asthmatic, anti-cancer, and anti-inflammatory effects.

CAS 918633-87-1 Evofosfamide

Evofosfamide
(CAS: 918633-87-1)

Evofosfamide, also known as TH-302, is a hypoxia-activated prodrug consisting of a 2-nitroimidazole phosphoramidate conjugate with potential antineoplastic act...

CI 924
(CAS: 79520-77-7)

CI 924 is hypolipidemic agent. It can elevate anti-atherogenic HDL and lower VLDL.

CAS 73870-35-6 Foresaconitine

Foresaconitine
(CAS: 73870-35-6)

Foresaconitine is a norditerpenoid alkaloid isolated from the processed tubers of Aconitum carmichaeli.

Chemical Structure

CAS 60-56-0 Methimazole

Quick Inquiry

Verification code

Featured Items